Grifols closes the third quarter in positive territory, pushing accumulated profits to €304 million through September

The Catalan multinational blood products company Grifols has earned 304 million euros up to September, representing an increase of 245% compared to the same period of the previous year, after closing the third quarter with a profit of 127 million, 146% more.